Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT.
| Image |  |
|---|---|
| Description | scientific article published in December 2004 |
| Author/s |
author: Paul V. Browne |
| Publication date | December 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |